TIRAP
TIRAP[edit | edit source]
TIRAP (Toll-interleukin 1 receptor (TIR) domain-containing adaptor protein), also known as MAL (MyD88-adapter-like), is a critical adaptor protein involved in the signaling pathways of the innate immune system. It plays a pivotal role in the Toll-like receptor (TLR) signaling cascade, which is essential for the recognition of pathogen-associated molecular patterns (PAMPs) and the subsequent activation of immune responses.
Structure[edit | edit source]
TIRAP is characterized by the presence of a TIR domain, which is a conserved region found in all members of the TLR family and their associated adaptor proteins. This domain is crucial for protein-protein interactions that facilitate downstream signaling. The TIR domain of TIRAP allows it to interact with other TIR domain-containing proteins, such as MyD88, to propagate the signal initiated by TLR activation.
Function[edit | edit source]
TIRAP functions as a bridging adaptor that links specific TLRs to the downstream signaling adaptor MyD88. It is primarily involved in the signaling pathways of TLR2 and TLR4. Upon activation by their respective ligands, TLR2 and TLR4 recruit TIRAP to the plasma membrane, where it facilitates the recruitment of MyD88. This recruitment is essential for the activation of downstream signaling pathways that lead to the production of pro-inflammatory cytokines and type I interferons.
Role in Disease[edit | edit source]
Mutations or polymorphisms in the TIRAP gene have been associated with altered susceptibility to various infectious diseases. For example, certain polymorphisms in TIRAP have been linked to increased susceptibility to tuberculosis and malaria, while others may confer protection against these diseases. The role of TIRAP in inflammatory and autoimmune diseases is also an area of active research, as dysregulation of TLR signaling can contribute to chronic inflammation and autoimmunity.
Related Proteins[edit | edit source]
TIRAP is one of several adaptor proteins involved in TLR signaling. Other key adaptors include MyD88, TRIF (TIR-domain-containing adapter-inducing interferon-_), and TRAM (TRIF-related adaptor molecule). Each of these adaptors is involved in distinct TLR signaling pathways, contributing to the specificity and diversity of the immune response.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD